Drug Recall: Dr. Berne's MSM Drops for Manufacturing Practice Violations
Dr. Berne's MSM DROPS 5% Solution is being recalled due to Current Good Manufacturing Practice (CGMP) deviations. The voluntary recall affects 3833 bottles distributed nationwide and internationally.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II voluntary recall initiated by the firm for CGMP deviations. Without details about specific manufacturing defects or reported adverse events, this precautionary recall warrants a moderate severity rating.
Plain-English summary
Dr. Berne's Whole Health Products is recalling Dr. Berne's MSM DROPS 5% Solution (30 mL/1.014 OZ bottles) due to Current Good Manufacturing Practice (CGMP) deviations discovered during manufacturing. The company initiated this voluntary recall on August 26, 2023, and the FDA classified it as a Class II recall on October 4, 2023.
Approximately 3833 bottles with lot numbers 6485, 6562, 6624, 6669, 6688, 6727, 6771, 6830, and 6887 are affected. The product was distributed nationwide and internationally to the UK, Canada, Italy, India, Australia, Germany, Switzerland, Singapore, the Netherlands, Ireland, South Korea, Belgium, Norway, Saudi Arabia, Slovenia, Malta, Israel, Sweden, Latvia, Portugal, Hong Kong, Kuwait, Romania, South Africa, Thailand, Zambia, France, Finland, Mauritius, and Barbados. Affected bottles have expiration dates ranging from November 2023 to July 2025.
Consumers who have purchased this product should discontinue use and contact Dr. Berne's Whole Health Products for instructions. The company can be reached at [email protected] or at 174 Tesuque Village Rd Unit 458, Tesuque, New Mexico 87574.
The recalled product
- Product
- Dr. Berne's MSM DROPS 5% Solution, 30 mL/1.014 OZ bottle, Distributed by: Dr. Berne's Whole Health Products, Tesuque, NM, 87574, [email protected], UPC 00854582001111.
- Manufacturer
- Dr. Berne's Whole Health Products
- Category
- Drug
- Hazard
- Affected units
- 3,833
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (17)
- Lot: 6485
- Exp: 11/23: 6562
- Exp: 03/24
- 6624
- Exp: 06/24
- 6669
- Exp: 08/24
- 6688
- Exp: 09/24
- 6727
- EXP: 11/24
- 6771
- Exp: 02/25
- 6830
- Exp: 03/25
- 6887
- Exp: 07/25.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Dr. Berne's Whole Health Products under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Dr. Berne's Whole Health Products
See all →- ModerateDr. Berne's MSM MIST 15% Topical Spray Recalled for Manufacturing Deviations
FDA (Drugs) · 2023-10-11
- HighDrug eye drops recalled for manufacturing practice deviations nationwide
FDA (Drugs) · 2023-10-11
- ModerateDr. Berne's MSM Drops Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-10-11
- CriticalFDA Recalls Dr. Berne's MSM Drops Due to Non-Sterility Concerns
FDA (Drugs) · 2023-10-11
Same hazard · manufacturing deviation
See all →- HighBaxter Recalls Vancomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateSynjardy XR Tablets Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2026-07-08
- ModerateDuloxetine delayed-release capsules recalled for N-nitroso impurity contamination
FDA (Drugs) · 2026-05-13
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06